Peiqiang Cai

781 total citations · 1 hit paper
43 papers, 490 citations indexed

About

Peiqiang Cai is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peiqiang Cai has authored 43 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peiqiang Cai's work include Colorectal Cancer Surgical Treatments (14 papers), Colorectal and Anal Carcinomas (12 papers) and Gastric Cancer Management and Outcomes (9 papers). Peiqiang Cai is often cited by papers focused on Colorectal Cancer Surgical Treatments (14 papers), Colorectal and Anal Carcinomas (12 papers) and Gastric Cancer Management and Outcomes (9 papers). Peiqiang Cai collaborates with scholars based in China, United States and Hong Kong. Peiqiang Cai's co-authors include Weiwei Xiao, Xiaofei Lv, Zhizhong Pan, Yi Fan, Ying Jin, Min Liu, Rui‐Hua Xu, Junzhong Lin, Gong Chen and Yanqing Gong and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Peiqiang Cai

40 papers receiving 486 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study

2023 77 citations Gong Chen, Ying Jin et al. The Lancet. Gastroenterology & hepatology profile →

Peers

Countries citing papers authored by Peiqiang Cai

Since Specialization

Citations

This map shows the geographic impact of Peiqiang Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiqiang Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiqiang Cai more than expected).

Fields of papers citing papers by Peiqiang Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiqiang Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiqiang Cai. The network helps show where Peiqiang Cai may publish in the future.

Co-authorship network of co-authors of Peiqiang Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Peiqiang Cai. A scholar is included among the top collaborators of Peiqiang Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiqiang Cai. Peiqiang Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular dynamics of 4H-SiC nano-grinding under dual abrasive particle coupling 2025 ·Materials Science in Semiconductor Processing ·(unknown), Jisheng Pan, Hanxiao Li, Jianping He, (unknown), Peiqiang Cai, Ping Yang	0
2	Application of responsive nano-drug carriers in bone tumor chemotherapy 2025 ·Journal of bone oncology ·Peiqiang Cai, (unknown), Pengfei Zheng	1
3	Beyond the tumor region: Peritumoral radiomics enhances prognostic accuracy in locally advanced rectal cancer 2025 ·World Journal of Gastroenterology ·(unknown), Ming‐Lung Yu, Hui Yang, Haojiang Li, Hui Xie, Chun-Yan Cui, Weijing Zhang, (unknown), Peiqiang Cai, Xiaofeng Lin, (unknown), (unknown), Lizhi Liu, Biyun Chen	0
4	Artificial Intelligence in Medical Imaging: Diagnosis and Beyond 2024 ·Journal of medical imaging and radiation sciences ·Peiqiang Cai	0
5	Crucial computed tomography and magnetic resonance imaging findings of fallopian tubal tuberculosis for diagnosis: a retrospective study of 26 cases 2024 ·Quantitative Imaging in Medicine and Surgery ·(unknown), Ke Zou, (unknown), (unknown), (unknown), (unknown), Peiqiang Cai, Ling Zhang, Liangjie Li	1
6	Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open‐label, multicenter, single‐arm, phase 2 trial 2023 ·Cancer Medicine ·Shuang Liu, (unknown), (unknown), Shoumin Bai, Xiaojun Wu, (unknown), (unknown), Haina Yu, Qiaoxuan Wang, Hui Chang, Zhifan Zeng, Peiqiang Cai, Zhizhong Pan, Yuanhong Gao, Gong Chen, Weiwei Xiao	2
7	Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study breakdown → 2023 ·The Lancet. Gastroenterology & hepatology ·Gong Chen, Ying Jin, Wen‐Long Guan, Rongxin Zhang, Weiwei Xiao, Peiqiang Cai, Min Liu, Junzhong Lin, Fulong Wang, Cong Li, (unknown), (unknown), Huizhong Zhang, Zhizhong Pan, Rui Wang, Rui‐Hua Xu	77
8	Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial 2023 ·Journal of Translational Medicine ·(unknown), Xiaodong Su, (unknown), Guangyu Luo, Zhiqiang Wang, Peiqiang Cai, Yating Zheng, Ting Bei, Mengli Huang, Yuezong Bai, Haoqiang He, Jin Xiang, Muyan Cai, Jiudi Zhong, (unknown), (unknown)	17
9	Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma? 2023 ·Thoracic Cancer ·(unknown), Xiaodong Su, (unknown), Guangyu Luo, Haoqiang He, Peiqiang Cai, Muyan Cai, (unknown), Zhi‐Qiang Wang, (unknown), Peng Lin, Xu Zhang	5
10	MRI-Based Radiomics Features to Predict Treatment Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer: A Single Center, Prospective Study 2022 ·Frontiers in Oncology ·Biyun Chen, Hui Xie, Yuan Li, Xinhua Jiang, (unknown), Xiaofeng Tang, Xiaofeng Lin, Li Li, Peiqiang Cai	18
11	High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer 2022 ·Radiation Oncology ·Qiaoxuan Wang, Shu Zhang, Weiwei Xiao, (unknown), Hui Chang, Zhifan Zeng, Peiqiang Cai, Zhenhai Lu, Gong Chen, Peirong Ding, Zhizhong Pan, Xiaojun Wu, Yuanhong Gao	1
12	Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series 2021 ·Frontiers in Immunology ·(unknown), Ting Jiang, Yajie Xiao, Qiaoxuan Wang, Zhifan Zeng, Peiqiang Cai, (unknown), (unknown), Dongfang Wu, Hanqing Lin, Chao Sun, Rong Zhang, Weiwei Xiao, Yuanhong Gao	11
13	Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection 2021 ·BMC Cancer ·Yan Yuan, Weiwei Xiao, Weihao Xie, Peiqiang Cai, Qiaoxuan Wang, Hui Chang, (unknown), Wenhao Zhou, Zhifan Zeng, Xiaojun Wu, Qing Liu, Li Li, Rong Zhang, Yuanhong Gao	13
14	Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation 2021 ·Cancer Management and Research ·Ling Zhang, Peiqiang Cai, (unknown), (unknown), Yonggang Li, Xinhua Jiang	18
15	Adjuvant Therapy for a Microscopically Incomplete Resection Margin after an Esophagectomy for Esophageal Squamous Cell Carcinoma 2017 ·Journal of Cancer ·Bo Qiu, (unknown), (unknown), Zhiqiang Wang, Ying Liang, Peiqiang Cai, (unknown), Meng‐Zhong Liu, Jianhua Fu, Hong Yang, Hui Liu	9
16	Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma 2016 ·Radiotherapy and Oncology ·Bo Qiu, (unknown), Hong Yang, (unknown), Ying Liang, Peiqiang Cai, (unknown), Meng‐Zhong Liu, Jianhua Fu, Chuan-Miao Xie, Hui Liu	14
17	A Rare Case of a Postoperative Submandibular Exophytic Goiter in a Patient With a Recurrent Normotopic Nodular Goiter 2016 ·Clinical Nuclear Medicine ·(unknown), Peiqiang Cai, (unknown), Jie Qin, Xiaoping Lin	2
18	The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer 2015 ·Medicine ·Guochen Liu, Xu Zhang, Enzehua Xie, Xin An, Peiqiang Cai, Ying Zhu, Jinghua Tang, Ling-Heng Kong, Junzhong Lin, Zhizhong Pan, Peirong Ding	7
19	Hypertrophic adenoids in patients with nasopharyngeal carcinoma: appearance at magnetic resonance imaging before and after treatment 2015 ·Chinese Journal of Cancer ·(unknown), Peiqiang Cai, Li Tian, (unknown), (unknown), Yi Fan, Zhenfeng Zhang	8
20	Computed Tomography Imaging of Anterior and Middle Mediastinal Ewing Sarcoma/Primitive Neuroectodermal Tumors 2010 ·Journal of Thoracic Imaging ·(unknown), Lingling Zhao, (unknown), Peiqiang Cai, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact